AstraZeneca's new TV ad for Farxiga focuses on chronic kidney disease indication
January 31, 2022 02:24 PM EST
Pharma
Marketing

As­traZeneca adds chron­ic kid­ney dis­ease TV ad to Farx­i­ga port­fo­lio

Beth Snyder Bulik

Senior Editor

As­traZeneca is adding a third ar­row to its Farx­i­ga TV ad quiver. De­but­ing to­day, the new com­mer­cial takes aim at chron­ic kid­ney dis­ease, fol­low­ing AZ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times